Smith & Nephew PLC (LSE:SN.) - Share price - Overview

Stock Report

Smith & Nephew PLC SN.

Last Price
GBX1,206.00

Day Change
-9.00|-0.74%

As of 23/02/2017
17:10:29 GMT | GBX
Minimum 15 Minutes Delay.

Last Close1,215.00p
Day Range1,206.00 - 1,220.00
Mkt Cap10.63Bil
52-Wk Range1,064.91 - 1,324.00
Yield %1.91
ISINGB0009223206
Volume2,276,421
P/E20.50
P/S3.57
P/CF15.51

Share Price

Total Returns 23/02/2017

 Chg (%)  
More ...
Smith & Nephew PLC1.34 
FTSE 100 TR GBP1.85
 
Financials
201420152016
More ...
Income Statement
Turnover2,809.363,017.54-
Operating Profit455.75408.94-
Net Profit304.85266.98-
Reported EPS33.8929.69-
Balance Sheet
Current Assets1,567.661,670.60-
Non Current Assets3,126.323,167.06-
Total Assets4,693.984,837.66-
Current Liabilities746.56907.19-
Total Liabilities2,098.352,160.65-
Total Equity2,595.632,677.02-
Cash Flow
Operating Cash Flow584.75783.36-
Net Change in Cash-32.8628.00-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017861.9871.7622.0016.930.7726.232.16
2018926.5578.078.7915.561.7729.042.39

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
25/10/2016PurchaseRt. Hon Baroness Virginia Bottomley of Nettlestone1,217.65897.00
25/10/2016PurchaseMr. Joe Papa1,217.65449.00
25/10/2016in Lieu of DividendOlivier Bohuon1,217.653,44941,997.00
15/08/2016in Lieu of DividendMr. Roberto Quarta1,290.004,39156,644.00

Company Profile

Smith & Nephew PLC develops, manufactures, markets and sells medical devices. Its segments include Advanced Surgical Devices and Advanced Wound Management.

Sector

Medical Devices

Market Position

45 of 1852 Companies

Index

FTSE 100 ,FTSE 350 ,S&P Europe 350 ,Eurotop 300 ,FTSE techMARK Focus

Outlook

(09/02/2017) "...the group expects to deliver higher revenue growth and an improved trading profit margin in 2017"

Next Event 30/03/2017

Ex Dividend
Ratios
CompSecMkt
More ...
PER (E)16.7217.7316.15
Div Yld (E)2.191.864.04
PEG (E)0.850.641.25
ROCE0.0031.07-29.76
Op Mrgn0.00-12.92-30.74
EPS Grwth19.7334.1938.65
Dividends
PreviousLatest
More ...
Record Date07/10/1631/03/17
Ex-Div06/10/1630/03/17
Paid25/10/1610/05/17
Amnt10.0815.06

Broker Sentiment

Strong Buy0
Buy1
Hold2
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Roberto Quarta
Chief Executive OfficerOlivier Bohuon
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.